In summary, when combined, the results of the experiments reported in this paper support the notion that epigenetic changes mediated by chromatin proteins, such as Nupr1, along with their effects on DNA methylation modulate the function of well-characterized oncogenes, which mutational activation occurs early during the development of cancers. This evidence concerns the gene NUPR1 and cancer.